The Karathanasis Laboratory for Cancer Nanotechnology focuses on cancer nanomedicine and its translational application on imaging and therapy. Our research program exploits the engineerable nature of nanoparticle technology to develop clinically relevant therapeutic and imaging agents for hard-to-treat cancers based on the integration of nanotechnology, oncology, imaging science and cancer biology. Specifically, we study the relation between the design of nanoparticles (e.g., structure, size, shape) and their navigation through different biological processes to extract design parameters that improve the overall in vivo performance of nanomedicines.
Our lab is located at University Hospitals Case Medical Center and is part of the Case Comprehensive Cancer Center and the Case Center for Imaging Research. To learn more about cancer and imaging research at Case, we encourage you to further explore the websites of our lab and its affiliiated centers.
|October 2014 - The Cancer Nanotechnology Lab was awarded a grant from the Prayers from Maria Children's Glioma Cancer Foundation | News release: Case Western researchers awarded $250,000 to develop an effective treatment for childhood brain tumors|
|August 2014 - Elizabeth Doolittle receives NIH fellowship from the Interdisciplinary Biomedical Imaging Training Program (T32EB007509)|
|April 2014 - Congrats to Gilad Doron for receiving a summer research scholarship | Gilad, an undergraduate research assistant in the Cancer Nanotechnology Lab, was selected as SOURCE 2014 Summer Research Scholar.|
|Location:||Wearn 310 & 314|
|Email:||stathis at case.edu|